Announcement of the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final ...

The Centers for Medicare & Medicaid Services (CMS) said Friday that it had selected another 15 drugs for its second round of ...

Announcing the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final health ...

Gladis Angarita, 62, fled her village in northeast Colombia in terror last Friday, among thousands escaping a fresh guerrilla ...

AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...

The two blockbusters Novo Nordisk medicines are among 15 additional drugs whose prices Medicare will be allowed to negotiate ...

The upcoming release of Phase III Fasenra data in COPD in 2025 is expected to solidify AstraZeneca’s position in the market.

FDA Commissioner Robert Califf is closing the book on his second stint leading the agency that regulates products accounting ...

Data collected from children with asthma and other respiratory conditions. Outcome measures Children/carers attending hospital were asked how they identify an empty salbutamol inhaler ... will be able ...

MRI of inhaled perfluoropropane can assess regional lung ventilation and monitor improvements in response to medication ...

A Reuters analysis shows that Berkshire coal plants emit more nitrogen oxide gases than any other coal-fired fleet in the ...

A new education program seeks to provide local prisoners with a sanitary space for tattoos and give students the foundation ...